Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
38
|
pubmed:dateCreated |
1967-10-28
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0024-7790
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
216
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
499-504
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:5976631-Adolescent,
pubmed-meshheading:5976631-Adult,
pubmed-meshheading:5976631-Aged,
pubmed-meshheading:5976631-Diabetes Mellitus,
pubmed-meshheading:5976631-Female,
pubmed-meshheading:5976631-Humans,
pubmed-meshheading:5976631-Hypoglycemic Agents,
pubmed-meshheading:5976631-Male,
pubmed-meshheading:5976631-Middle Aged
|
pubmed:year |
1966
|
pubmed:articleTitle |
[Contribution to the study gf a new oral antidiabetic: glycodiazine].
|
pubmed:publicationType |
Journal Article
|